Antidepressant-induced lipidosis with special reference to tricyclic compounds

Progress in Neurobiology

Volumn 60, Issue 6, 2000, Pages 501-512

  Xia, Zhenlei ^a   Ying, Gu ^a   Hansson, Ann Louise ^a   Karlsson, Håkan ^a   Xie, Yi ^a   Bergstrand, Anders ^a   DePierre, Joseph W ^a   Nässberger, Lennart ^a  

^a STOCKHOLM UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOPHILE; ANTIDEPRESSANT AGENT; PHOSPHOLIPASE; SPHINGOMYELIN PHOSPHODIESTERASE; TRICYCLIC ANTIDEPRESSANT AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; DEPRESSION; ELECTRON MICROSCOPY; ENZYME INHIBITION; FOAM CELL; GLIOMA; LIPID METABOLISM; LIPIDOSIS; LUNG ALVEOLUS MACROPHAGE; NEUROBLASTOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; HUMANS; LIPIDOSES; PHOSPHOLIPIDS;

EID: 0033965926     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(99)00036-2     Document Type: Review

References (55)

1. Albouz S., LeSaux F., Wenger D., Hauw J.J., Baumannn N. Modifications of sphingomyelin and phosphatidylcholine metabolism by tricyclic antidepressants and phenothiazines. Life Sciences. 38:1983;357-363.
2. Albouz S., Vanier A.T., Hauw J.J., LeSaux F., Boutry J.M., Baumann N. Effect of tricyclic antidepressants on sphincomyelinase and other sphingolipid hydrolases in C6 cultured glioma cells. Neuroscience Letters. 36:1993;311-315.
3. Ashman R.B., Blanden R.V., Ninhan B.W., Evans D.F. Interaction of amphiphilic aggregates with cells of the immune system. Immunology Today. 7:1986;278-283.
4. Audus K.L., Gordon M.A. Tricyclic antidepressant effects on the murine lymphocyte mitogen response. J. Immunopharmacol. 4:1982;13-27.
5. Bockhardt H., Lullmann-Rauch R. Zimelidine-induced lipidosis in rats. Acta Pharmacol et Toxicol. 47:1980;45-48.
6. Dake M.D., Madison J.M., Montgomery C.K., Shellito J.E., Hinchcliffe W.A., Winkler M.L., Bainton D.F. Electron microscopic demonstration of lysosmal inclusion bodies in lung, liver, lymph nodes and blood leukocytes of patients with amiodarone pulmonary toxicity. Am. J. Med. 78:1985;506-512.
7. Dreckhahn D., Lullmann-Rauch R. Experimental myopathy induced by amphiphilic cationic compounds including several psychotropic drugs. Neuroscience. 4:1979;549-562.
8. Drenckhahn D., Kleine L., Lullmann-Rauch R. Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. Lab Invest. 35:1976;116-123.
9. Drenckhahn D., Lullmann-Rauch R. Differential susceptibilities of pigment epithelium and neuroretina toward several amphiphilic cationic drugs. Exp. Mol. Pathol. 28:1978;360-371.
10. Drew R., Siddik Z.H., Mimnaugh E.G., Gram T.E. Species and dose differences in the accumulation of imipramine by mammalian lungs. Drug Metabolism and Dispos. 9:1981;322-326.
11. Fauster R., Honegger K., Wiesman U. Inhibition of phospholipid degradation and changes of the phospholipid-pattern by desimipramine in cultured human fibroblasts. Biochem. Pharmacol. 32:1983;1737-1744.
12. Federico A., Palmeri S., Malandrini A., Fabrizi G., Mondelli M., Guazzi G.C. The clinical aspects of adult hexosaminidase deficiencies. Dev. Neurosci. 13:1991;280-287.
13. Federico A., Palmeri S., Malandrini A., Mangano L., Ciacci G., Scarpini C., Tiacci G. Dementia, myoclonus, peripheral neuropathy and lipid-like material in skin biopsy during psychotropic drug, treatment. Biol. Physchiatry. 32:1992;721-727.
14. Ferjan I., Erjavec F. Changes in histamine and serotonin secretion from rat peritoneal mast cells caused by antidepressants. Inflam. Res. 45:1996;141-144.
15. Foerstl J., Hohagen F., Hewer W., Pohlman-Eden B. Another case of Creutzfeldt-Jacob like-syndrome due to antidepressant toxicity. J. Neurol. Neurosurg. Psychiatry. 52:1989;920-926.
16. Frisch W., Lullmann-Rauch R. Differential effects of chloroquine and of several other amphiphilic cationic drugs upon rat choroid plexus. Acta. Neuropathol. (Berl.). 46:1979;203-208.
17. Geist S.H., Lullmann-Rauch R. Experimentally induced lipidosis in uterine and vaginal epithelium of rats. Annals Anatomy. 176:1994;3-9.
18. Greselin E. An inhibitor of cholesterol biosynthesis and the alveolar macrophages. Can. J. Comp. Med. Vet. Sci. 30:1966;121-126.
19. Hansson A.L., Xia Z., Berglund M.C., Bergstrand A., dePierre J.W., Nässberger L. Reduced cell survival and morphological alterations induced by three tricyclic antidepressants in human peripheral monocytes and lymphocytes and in cell lines derived from these cell types. Toxicol. in Vitro. 11:1997;21-31.
20. Howell J.I., Fisher D., Goodall A.H., Verrinder M., Lucy J.A. Interactions of membrane phospholipids with fusogenic lipids. Biochim. Biophys. Acta. 332:1973;1-10.
21. Hostetler K.Y., Matsuzawa Y. Studies on the mechanism of drug-induced lipidosis cationic amphipathic drug inhibition of lysosomal phospholipases A and C. Biochem. Pharmacol. 30:1981;1121-1126.
22. Hruban Z. Pulmonary and generalized lysosomal storage induced by amphiphilic drugs. Environmental Health Perspectives. 55:1984;53-76.
23. Irman-Florjanc T., Stanovnik L. Tricyclic antidepressants change plasma histamine kinetics after its secretion induced by compound 48/80 in the rat. Inflam. Res. 47:1998;s26-s27.
24. Jägel M., Lullmann-Rauch R. Lipidosis-like alterations in cultured macrophages exposed to local anaesthetics. Arch. Toxicol. 55:1984;229-232.
25. Joshi U.M., Kodavanti S., Couderts B., Dwyer T.M., Mehendale H.M. Types of interaction of amphiphilic drugs with phospholipid vesicles. J. Pharmacol. Exp. Toxicol. 246:1988;150-157.
26. Joshi U.M., Rao P., Kodavanti S., Lockard V.G., Mehendale H.M. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies relevance to phospholipidosis. Biochim. Blophys. Acta. 1004:1989;309-320.
27. Lehnert B.E., Ferin J. Particle binding phagocytosis and plastic substrate adherence characteristic of alveolar macrophages from rats acutely treated with chlorphentermine. J. Reticuloendothel. Soc. 33:1983;293-303.
28. Leli U., Hauser G. Modifications of phospholipid metabolism induced by chlorpromazine, desmethylimipramine and propanol in C6 glioma cells. Biochem. Pharmacol. 36:1987;31-37.
29. Lullmann H., Lullmann-Rauch R., Rell G.H. A comparative ultrastructural study of the effects of chlorphentermine and triparanol in rat lung and adrenal gland. Virchows Arch. Cell. Pathol. Abt. B 12:1973;91-103.
30. Lullmann-Rauch R., Reil G.H., Scheid D. Lipidosisähnliche Zellveränderung bei der Ratte nach Behandlungmit Thymoleptika. Verh Dtsch Ges Path. 57:1973;425-431.
31. Lullmann-Rauch R. Liplidosis-like ultrastructural alterations in rat lymph nodes after treatment with antidepressants or neuroleptics. Naunyn-Schmiedeberg's Arch. Pharmacol. 286:1974;165-175.
32. Lullmann-Rauch R. Lipidosis-like alterations in dorsal root ganglion cells of rats treated with tricyclic antidepressants. Naunyn-Schmiedeberg's Arch. Pharmacol. 283:1974;219-222.
33. Lullmann-Rauch R. Lipidosis-like renal changes in rats treated with chlorphentermine or with tricyclic antidepressants. Virchows Arch. Abt. B Cell Pathol. 18:1975;51-62.
34. Lullmann-Rauch R., Scheid D. Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs. Virchows Arch. Abt. B Cell Pathol. 19:1975;255-268.
35. Lullmann-Rauch R. Retinal lipidosis in albino rats treated with chlorphentermine and with tricyclic antidepressants. Acta. Neuropath. (Berl.). 35:1976;55-67.
36. Lullmann-Rauch R., Nässberger L. Citalopram-induced generalized lipidosis in rats. Acta. Pharmacol. et. Toxicol. 52:1983;161-167.
37. Mårtensson U., Nässberger L. Influence of antidepressants on mitogen stimulation of human lymphocytes. Toxicol. in Vitro. 7:1993;241-245.
38. Martin W.J., Kachel D.L. Iprindole reverses the lamellar body deficiency of cultured L-2 cells. Am. J. Pathol. 129:1987;34-43.
39. McNulty M.J., Reasor M.J. Iprindole-induced phospholipidosis in rat alveolar macrophages: alterations in oxygen consumption and release of oxidants. Exp. Lung. Res. 2:1981;57-69.
40. McNulty M.J., Reasor M.J. Enhanced phagocytotic and bactericidal activities of phospholipidotic rat alveolar macrophages. J. Reticuloendothel. Soc. 30:1983;539-549.
41. Navon R., Baran D. Depletion of cellular β -hexosaminidase by imipramine is prevented by dexamethasone; implications for treating psychotic hexosaminidase-A deficient patients. Biochem. Biophys. Res. Commun. 148:1987;1098-1103.
42. Palmeri S., Mangano L., Battisti C., Malandrini A., Federico A. Imipramine induced lipidosis and dexamethasone effect: morphological and biochemical study in normal and chronic GM2 gangliosidosis fibroblasts. J. Neurol. Sci. 110:1992;215-221.
43. Reasor M.J., Koshut R.A., McNulty M.J. Chemiluminescence from rat alveolar macrophages following induction of phospholipidosis with chlorphentermine. Toxicol. Appl. Pharmacol. 52:1980;497-506.
44. Robb R.M., Kuwabara T. The ocular pathology of Type A Niemann-Pick disease. Invest. Opthalmol. 12:1973;366-373.
45. Sauers L.J., Wierda D., Walker E.R., Reasor M.J. Morphological and functional charges in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine. J. Immunopharmacol. 8:1986;611-631.
46. Sauers L.J., Wierda D., Reasor M.J. Chlorphentermine suppresses the phosphatidylinositol pathway in concanavalin A activated mouse splenic lymphocytes. Immunopharmacol. Immunotoxicol. 10:1988;1-9.
47. Seydel J.K., Wassermann O. NMR-studies on the molecular basis of drug-induced phospholipidosis II. Interaction between several amphiphilic drugs and phospholipids. Biochem. Pharmacol. 25:1976;2357-2364.
48. Vijeyaratnam G.S., Corrin B. Pulmonary histiocytosis simulating desquamative interstitial pneumonia in rats receiving oral iprindole. J. Pathol. Bacteriol. 108:1972;105-111.
49. Wold J.S., Joost R.R., Griffing W.J., Marroquine P., Harris P.N. Phospholipid accumulation in rats produced by fluoxetine and chlorphentermine. Toxicol. Appl. Pharmacol. 37:1976;118-119.
50. Xia Z., dePierre J.W., Nässberger L. Tricyclic antidepressants inhibit IL-6. IL-1 β and TNF α release in human blood monocytes and IL-2 and interferon γ in T cells. Immunopharmacol. 34:1996;27-37.
51. Xia Z., dePierre J.W., Nässberger L. The tricyclic antidepressants clomipramine and citalopram induce apoptosis in cultured human lymphocytes. J. Pharmacy. Pharmacol. 48:1996;115-116.
52. Xia Z., Appelkvist E.L., dePierre J.W., Nässberger L. Tricyclic antidepressant-induced lipidosis in human peripheral monocytes in vivo, as well as in a monocyte-derived cell line, as monitored by spectrofluorimetry and flow cytometry after staining with Nile red. Biochem. Pharmacol. 53:1997;1521-1532.
53. Xia Z., Karlsson H., dePierre J.W., Nässberger L. Tricyclic antidepressants induce apoptosis in human T-lymphocytes. Int. J. Immunopharmacol. 19:1997;645-654.
54. Yamamoto A., Aduchi S., Imoto T., Nishikawa N. Studies on drug-induced lipidosis III. Lipid composition of the liver and some other tissues in clinical cases of "Niemann-Pick like syndrome" induced by 4,4-diethylethoxyhexestrol. J. Biochem. (Tokyo). 70:1971;775-784.
55. Yates R.D., Arai K., Rappoport D.A. Fine structure and chemical composition of opaque cytoplasmic bodies of triparanol treated Syrian hamsters. Exp. Cell Res. 47:1967;459-478.